Short description
Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases.
Description
Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases. Its lead compound, ARA 290, a novel 11 amino acid peptide, stimulates tissue protective, reparative, and anti-inflammatory signaling pathways through selective IRR activation.
Araim Pharmaceuticals is based in Tarrytown, New York.
Total funding
$$43214321
Sign in for full access
Location
Tarrytown, New York, United States, North America
Founded on
January 1, 2006
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Founders
Anthony Cerami, Michael Brines